Article Information
History
- November 16, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 16, 2020 - 10:57).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Leila B. Giron1,
- Harsh Dweep1,
- Xiangfan Yin1,
- Han Wang1,
- Mohammad Damra1,
- Aaron R. Goldman1,
- Nicole Gorman1,
- Clovis S. Palmer2,3,
- Hsin-Yao Tang1,
- Maliha W. Shaikh4,
- Christopher B. Forsyth4,
- Robert A. Balk4,
- Netanel F Zilberstein4,
- Qin Liu1,
- Andrew Kossenkov1,
- Ali Keshavarzian4,
- Alan Landay4 and
- Mohamed Abdel-Mohsen1,*
- 1The Wistar Institute, Philadelphia, PA, 19104, USA
- 2The Burnet Institute, Melbourne, Victoria, 3004, Australia
- 3Department of Infectious Diseases, Monash University, Melbourne, Victoria, 3004, Australia
- 4Rush University, Chicago, IL, 60612, USA
- ↵*Corresponding author: Mohamed Abdel-Mohsen, Ph.D. Assistant Professor, Vaccine and Immunotherapy Center, The Wistar Institute. 3601 Spruce Street, Philadelphia, PA 19104. Phone: 215-898-6008. Email: mmohsen{at}Wistar.org